Peng Yin

Peng Yin currently serves as Chairman and CEO of Accucise Diagnostics Inc. and as Senior Vice President and CTO of Sansure Biotech Inc. Peng has an extensive background in clinical chemistry and diagnostics, having held the position of Executive Committee Member in the Emerging Technology Division of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) since 2018, and as a Fellow of the National Academy of Clinical Biochemistry with the American Association for Clinical Chemistry since 2014. Peng has also contributed to various editorial boards, including the Journal of Virology & Current Research and the Journal of Human Virology & Retro Virology. Prior experience includes co-CEO at Biotime and significant roles at Abbott, where Peng led Research and Development efforts in Asia. Educational qualifications include an MBA from Lake Forest Graduate School of Management, a postdoctoral fellowship in Molecular Virology and Oncology from Harvard Medical School, a PhD in Molecular Virology from the University of Manitoba, and an MD from Tianjin Medical University.